45583503 PET/CT | Cancer Diagnostic - ⁶⁸Ga-PSMA


  • Home
  • PET/CT | Cancer Diagnostic - ⁶⁸Ga-PSMA

PET/CT imaging for prostate cancer patients becomes more accurate and available

RSU Nuclear medicine clinic offers more accurate and available PSMA PET/CT scan for prostate cancer patients using new radiopharmaceutical ¹⁸F-PSMA.

The new radiopharmaceutical ¹⁸F-PSMA is alternative to ⁶⁸Ga-PSMA-11 and has been developed and implemented in cooperation with the Center of Nuclear Medicine, Radiology Research Laboratory Riga Stradins University, and leading foreign radiology research centers and clinics. The new radiopharmaceutical is more sensitive at lower PSA levels, which guaranties even more accurate detection of prostate cancer.


Contact Us

If you have any questions please feel free to contact our customer support centre.
Our specialist will answer you as soon as possible, but not longer than 24 hours (on working days).

medvision logotype
© Rīga Stradiņš University Nuclear Medicine Clinic